After 6 months, at the end of successful TB treatment, we saw GPR183 expression significantly increased (p = 0.0156) in TB + T2D patients to a level comparable to the TB patients without T2D (Figure 1B). This evidence concerns the gene GPR183 and type 2 diabetes mellitus.